Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...
“Innovative technology leads the future”, Era Biology closely follows the theme of this exhibition and leads the development of microbial diagnosis to intelligence.
The world’s first au...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Era Biology has launched a new product series which is Chemiluminescence Immunoassay (CLIA) detection kit for detecting inflammation and bacterial infections. The kit is run on Full-Automatic Chemi...
Meet Era Biology at Africa Health 2022
The 11th annual Africa Health 2022 exhibition will be held in Gallagher Convention Center, Johannesburg, South Africa on 26th-28th October.
Africa Health is t...
These series of methods are assays by utilizing specific viral antigen to detect antibodies in patients’ serum, including IgM antibodies detection and IgG antibodies measurement. The IgM antibodies...